-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, K+OIdX2mtW+oickkMtIucQPOo0h7RckZIoEIYQznPE4zANgrT4Hhhq5MLFlBr+Pc xKIkxvsXep2WlfSj81QwOg== 0000950123-10-079211.txt : 20101220 0000950123-10-079211.hdr.sgml : 20101220 20100819170529 ACCESSION NUMBER: 0000950123-10-079211 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20100819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 CORRESP 1 filename1.htm corresp
     
(GENOMIC HEALTH LOGO)
  Genomic Health, Inc.
301 Penobscot Drive
Redwood City, California 94063  
www.genomichealth.com
August 19, 2010
VIA EDGAR
John Reynolds
Assistant Director
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:    Genomic Health, Inc.
Form 10-K for Fiscal Year Ended December 31, 2009
Filed March 15, 2010
File No, 000-51541
Definitive Proxy Statement on Schedule 14A
Filed April 29, 2010
File No. 000-51541
Dear Mr. Reynolds:
     In response to the comments received from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) in its letter to Genomic Health, Inc. (the “Company”) dated August 11, 2010 and in furtherance of your telephone conversation with Gabriella Lombardi yesterday, this letter will confirm that the Company intends to respond to the Staff’s comments on or before September 15, 2010.
     Thank you for your consideration in this matter. Should you have any questions, please call the undersigned at 650.569.2290 or Gabriella Lombardi at 650.233.4670.
         
  Sincerely,
 
 
  -s- G. Bradley Cole    
  G. Bradley Cole   
  Chief Operating Officer and Chief Financial Officer
Genomic Health, Inc. 
 
 
cc:    Kimberly J. Popovits, Genomic Health, Inc.
Gabriella Lombardi, Pillsbury Winthrop Shaw Pittman LLP

GRAPHIC 2 f56722f5672201.gif GRAPHIC begin 644 f56722f5672201.gif M1TE&.#EABP`\`/<``,K*RMSH^.CI:6EDU-39B8F$-#0UY>7O+R\G9V=J*BHG%P<&YN;FUL;82$ MA*2DI'Q\?)*2DH&`@'1T=%M:6G)R,G)R=34U.GIZ;^^O]G9V<+"PKFY MN?#P\.3DY-O;V[N[N_?W]][>WM#0T.;FYK2TM/O[^]?7U^[N[O;V]K"PL.+B MXL3$Q-'1T9^>G^_N[\W-S=_>W^WM[WM\C(R+>VM\7%Q=_?W[BW MN,'!P;:UMK^_O\_/S_W]_>_O[MC8V.#@X,W,S923E+:VMM75U;2SM,3#Q*VM MK;&PL<_/SI^>GH:%ANSL[*NKJZFIJ9B7F*:EIGIY>MC7V(B'A\C'Q]_?WJVL MK;6UM:BGJ/S\_+JZNM?6UM33U*^NKI:5EG]_?\?&Q[NZN\"_OY&1D82#A*^O MK[Z]OIN;F[R[O'AW=^CHZ')Q<9^?GN/CXY^?GZ2CI,'`P,[-S82$@[:VM'Q\>YZ>GI>7EZRLJW9U=;NZ MNMW=W;N[NN/BXVMK:Z^OKI24DZ>GI]K:VHR+C)V=G=;5UMK9V7IZ>>;EYL;& MQ71S=.?GYI*2D5=65Z"?H)B8E]#/S_?W]KBWMV]O;^?FYXB'B)65EZZMKLO+RYZ=GL/"PG1S<[6UM&AH:*:EI6=G9YRW:BHIXN+BWEY><_.SMS; MW)Z>G;:UMVMO___R'Y!```````+`````"+`#P```C_`/\)'$BPH,&# M"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'$FRI,F.P#`!.\FR)<$@ M5J(50,A!2IX>"!G8L)3#I4^-.H@!B8$P"8T451!VL2$ASD^(!7"($($CP<@? M/ZP:;#*IU0Z$4_X@2.C%3+IX"7F,:1+D*0\CB&C$D!&C!A,E,S_N(4'48!`A M-WA0[%&$CHR$.Q39\*&UY0]`=`)$`-.IP:@P5&80^;AEG)B/:7#,4*C"U;DX M.%H6T&&#C)`:/HS\,")#AY/%0_)N-"*D<;/Y:4XM4W2;Y!$*@`X="V/$_PB@G:&.;5&X6*>(`P"9)FDXZHBQ)/6_ M!#^:Z&C"1(?@?P6T(4<,Y2G$@QAQ%+A>0X+04<07"K)'`Q(-;%8`$M'8P`D9 M5+#1@Q&;!8$$(%HLEU`")B[(D`(VW*#':`T%T0065L1WT`QBW#!3`7(MH8,/ M;=0@Q!6^"#%3`C[84`-QL/VG(D9\D%!$$?8Q5(,>-7QA!$)HM"C0##%0,0`. M:B10``\\T6`7@&IF4E`$A##P9$8X"&%#E0R]4$0.6VR!T#U.R"'0%U[T9=`/ MH;PR4!>R^/;%(DK,Z9,'N2!AP"0(U3+#805(X`.,L^7`ED!5Q,"$0#<<`:.D M"#F95JMX#O\T!`ZN_J/'BR2TP24;ZK7BA`__!"%.#VV`<4L#.,3G!`W)%N`# M(RDF4\,D*ZQ01@UX*,'$#P(%`<<6$UQBAQ%M%9`#'%&4Z-S: MPR1W8!"K0D^\]@\-0@CQSQ(^_`!+(0F@84LT/0210@\TC`/%$W)$2E`!VQ!@ M@%9,]-&,.SIP^P@'BN0E0P@M'($%%WIP0$$?$#1!Q!.S=+"(0&<@8P($>?%A M#@HI8#$#%A[D40D%`2B1`!0$8-`"-G<50H(#%AQ`1!`%H.(*)A@,-(D#GL10 M;@PX/31#%P'\$T\FEN`0!A+E**$$6SJ`AZ#@(`9+<&L2`2#.'.ZP"3L01`JE MV``5_H&$4D3`"P.QP@2*H`J!2(-P71C(&#Y`CN%A`1D14,0$!>($83C`&F`0 M"`A.L`PY">0)SYA%)<8P$!*``1S[:,(-_RU```@()`XOD$(?+#(#+1SF!F"` M0PY(48##A,$).@B"()Y0!R[8`@X""<,4XC>0.8P``WH@B`GP,8'/9*`9>C`# M#:H0A@>\0!$G$(@$]M`'*`P$%L_XQ?!R8`%!6*`7`^&!!U@Q@@X(Q`/KJQ(< M7+`-#A!D#\_X@P)@5`,#5*((`#K!`]RP!HN,X10H"P`:UA`(6^A`%`%H1#'D M5`#*Y"`*81#(`Y@QBH+(@``::`=!L,$"`ARF#\.``03QG"'%RB@+0*91`1.H`#1^:`2K,#4#T9PAU2< MJB(,F.,_JF`()Q#A!CFH0A6>D`,S*``6-$!$`<0@A,/TX`O1*`@/\@#4^)7A M&8N8!`\2X(!F:""N")E$)3A@`Q$N(F?_F!T^,)!3$/!B$1>0(30L.9`Z".,9 MW[#1/R:A`D@T(R\-8,$))I$`*VAR`QBTB`R.!-(#9I!TW]8H;@: MV))`K.`"P8+R'R#`QB+JF5@"T,`%EXR#,A2!!X&@H0\G2$(0$C`.`_3U(C)` M0@W^80,G#"$(`ZA/#&R@`R:$R:LWN,)^D6`+/Q:D!Q.X`!>HL(8`)(,@9X"$ M`MP0H21``A<._D<,%M$"$P3+`2W8`'@$8H,+F&,$`/@I"SC`+8'$H`)_:`%! M()`!1>P!1F-HP3WT$)\KA(`"FH@.170`!@`4(!.($-0/0-&`F#9`#'!0@@\* MT0,\""H0L8A$0=A@`VI802$@",$Z3A%.`#G!_Q0"28(#GK&N[2[@'<.S;CC& ML0BM)$(/L[#'0"9@"@<@-;$M6``*"-*%/YC`%#91UR"#6<(M_Z`,(0B`"&YQ`A7SQX`,`.I`"%&XB8 M##N@`1F@T)<(`/ZO`/)M`!$3+H M`15J\`-=:)<2:C?(%8KX/W(G@`L9>,!W)]\2!D2B$^&\;0/D-(0R-($!8)!$ M##A_GPSX09T"80,OLB"*@@2"`%M(;1!$@P0DA(0((N!&&YZA$-$(01&#*`G_ M#XJP*8$PX3BC68T?9&`$W2#BU7A2`S$4<("K$20?SEA$:M0`A"+8T0/E,0-/$`!SL1QGT`PN MX`P(@`#;@`P'$`@%,088X"(C<0QDX``,<0\#D`4GD09.<"UYH01+<`.D(`.A MI@3B@01E("@(D0-^4`XWD`2-4R`UP`'EX!0BL0,[<`\#$0-/<`0S*!#M8`:4 MT!+V``",(1!#H`,YH`3!!P>(P``U@'86$0#QX`-H_R$2)$`U`Y$%:!`/ZC$0 M1!`,19!++%$(L&`&AF(N4U`.H*@%3H`$&%@1->`&<7```#(#5U`%M@:(C#!' M!%(0"9`#;W"`-5`>>:`%P3`04&`#0/`$=;<91*`,.V!_,0`$48`(*<(1/1!J M!A$A%2$#XV`(C%``;J`'-$`""+`%6D$$;Y`($$`#/9`%$;!"_S`-0/`(#0`F M'6`'UC<04A`#)2`0'9`$KY`%_)`%#O`5W8`+-U`&,A`/>@`$>2`%\2`ZM!<1 M?H`+67`%.X!<_U`.7"`%5W4#$4`'7V%=>=!L_\`#B\`'[3`/`F$+1?``!!$' M-B40=:`%AH``B)`#NR`8A_]P#V1``W0`(YL0!S5@?P\)$3H0`93P!OTP$'IP M!#=P&'6P!7GP`&!D,;:@!X>!`UT@!&Q@#`*1`4!'$$``!9=01E-``MHE$$2P M`GP0!^05!4G`!3XWE!`!"_>0!2!W!UE M$'^P`W$I$&9@`RR0%SNP!`=PASD)"(Y`$(1``@V0"'()$53@`$=@@@/Q!ENP M&"P5`WH@!0@0`8_P`/27!#DU$`H`"%(X$(2P`R>@%3:P!DEPAT3@`'D`#01A M!GP`!H?7F0J!!)`@!:(I$%=`"ZN0%`?P!@:I$%B0`U1P!300#Y3P@K9R`[PP M$#?_X`5Z<(D"\0/-(`,A]@]0D`2RT)S(N1"PH``)21!7\&]$D012,``KYA<<)D# M401:D$<*N@12X)!UMP([P)D#\01?T`#'*:0%(01YP`@`>)%9T)2W%@]T\`#U M*%V'80-H(`@F6@4*\`"20!!?8`-_0(TVT`4W8'U#@(PCT["3!LH'=!"D:DH0 M:E`#44`#`(`'1*`&@=``AE`&3P`>0Y`%>=`(-=`#7%`.4D`#2I`#DT"JVA`% M3[`)-[`%1X`'.5`#2IH+8Y18RY`'H4`#K```-0`%0%`&DE`#6#`$AY`%>C`( M=3BI!V$#@D`"1Y`'A&!T![`%C"`'1S"C;#``AK`#M2`!A'!5_U`'$I`+$#`' M/`($-P`$:F`#DS``6A`&<^!@AT`(CK`##<`#0&`+L3``CC`'5F`$4?D%"`"> 6TMJP#ONP$!NQ$CNQ%%NQ%CNQ`0$`.S\_ ` end GRAPHIC 3 f56722f5672202.gif GRAPHIC begin 644 f56722f5672202.gif M1TE&.#EA``%$`.8``/[^_JJJJE5557]_?XV-C7%Q<>+BXL;&QM34U/W]_2HJ M*C@X./S\_+^_O_O[^S\_/_KZ^@```/CX^/GY^?;V]AP<'/3T]/+R\O7U]8Z. MCE965O?W]]O;V\C(R._O[UA86("`@-#0T.[N[G)R?GYY"0D+R\O*NKJ^;FYEU=74%!05=75WQ\ M?*2DI*ZNKJ6EI?#P\-W=W=/3TXR,C#T]/;>WMW-S<^#@X,K*REQ<7-G9V;&Q ML=[>WJBHJ&UM;3`P,,?'Q[Z^OL#`P'EY>4!`0,[.SN3DY)65E>SL[+BXN+"P ML'U]?8.#@Z^OK]?7U\W-S;:VMG1T=)24E(^/CY.3D_'Q\>CHZ./CXYJ:FF-C M8XB(B*"@H(*"@O___P`````````````````````````````````````````` M`````````````````````````````````````````````````"'Y!``````` M+````````40```?_@&B"@X(#"(2'A(J'`0,/`8J1DI.4@A0,B@3EYN>4!@.KD@@"Q.0K`4Q;*S/DH!$QZ`X*9O%PP9!%A)T./-!;:6J/7%67(77[LV=!>I&&S``ZLZMTI(( MNG#!@R`&?TG4T&!X4E,T#P0HU2:W$X((GQXD/A:`0$=.`M[VZA(#36=F@APD M0),!Q./2:"8.4W"?S+ZTYIZ M$1EC#0'83:,`-G;AQ9-3H*PY"`1P"O(!"6@DT`,(3T32%'_G((!I,7M2!I%L MY`2SZ2ZKL&?EAX"BH0HH52(S"`DIH@&`;)C-.X-496HU M&RDP+"\`$INL(FTE!^8!Q!3@Y2@O5H65M)%4-.H!C=AF;"\630>L)#^^I6L^ M`J29'7/E3+?E(-*R@NV''.'RSR"\3LLK`;XN8E%`!&C*2VV0X*HNC/B5268Y M#1Z+;+_5"-!`B!(_-=O_I;CX*FI.$EOT2#NI#?GQ+@T.$G(DB!;CG([D:&69 M.;C&U.`!C4$(72S^!!O!E02O0W.Z_84)K\"ZU/86D$(2\BXE"#AL"EWES*M/ M*I5$L'`H5PUB';01XHG&UM]9!9Y3&I*"0+WXWHC``H\E/8F>KQSS8SFJ'%S. M;)&`>LII@]080`,\'>>GQ.T,T",NP33FZ9DW1E`S(9?R#6[*U#3`VCY2"^1V M*10%NX"FCM?&'3OG#GGO83]:6`G0B$R+A@+V^2F)==2=3=O5O&Q=6S[JV`VO MZJ9$R+RT)HM;>^G@GI1]C'2.N5W,` M_]N=+`#Q6CWZ@ZM-E(R_/;V8IO)O3KZC44"&A!B`?]_?5E7_1&@@WWV`]PD! M2D-L@EC5.7"7MI>5XC6#H!PELN01H2E"&S>1W"06AZ_#H8%#ZG%@X;3Q/L99 M3A0>=PI^V2A\BU`%#@=AM:S0$`T1*%O8]F2`SS%K M*@2$&$'5+.L3F?O$,#HQ/MU$L0!&S(55:`(HBH1K6`O882CB8K-C^>>' MF=C<(,#D'7^4D&./F9X@_A&93DP'API80`4$,3Y@76G&\0`\!,,.QRPOZ`4/\0'LQ*O\CDB$D",2:2 M2(U3*"@(#7J")X3R1"-:\0@$`$Y3F;P:3_;4"E"LLE`*U!J8*!*[[>`L8?\H MFSJ\%$5"X*XG$A,15M]T)8!O#8)M&TE3-&&Q#NZD`B81!,^S^'6<`>PS?\/:/*CR!C,*03_J``[V`@MJ@Y$,F=3ZASCY8^D1L=ZVJE$4A5A M%9DDL4S(BXE[TO66I(D5%32KB_R$T9;:F/)#F<17*9EF$1K9$@'OT]L$*;.] M31+B`0IX8V5NPA.K/?*RE3D45`YE$W&I1 M5[C20,`\X<5T"5>6---%S(2[T[^>0D_UNUM%720)`+1*5@:>1F8%`0(-:*`) M(`@%_RM,*Z-*0-8[L2+#MP)&=A`!4L(P@>\T((,5%@_ MR'OQ.83S(@=```():)0G#$QB3L#@!U>`00=:T`%JC)C'5&K)CXC!.AE7@P$2 MF`"4*3`!"$C`R:9`^W,YSXO`F\Y&9F?!TUHB':OH86FB(C&]8!`AE MHB<=BD9#!)'2N22E656)],C*TSOVA7#:+.D+QG+3O'C3!)`Q@55_PM(;`(`# MH'R!"3@``TLJ\`0D`&I=2)D:5<'MZ5!="0A0P`(7P(`$'/^@8TDD0,IKLC*O M3P&!#03&312@`!H8<&9.C)H2LN:V!)8=&'!+@`+-]@4XEW=28D_"2(VR@`-X M+8%:WSK7R'A1`B2P`0=86L3=CA2<_HU@<(?X,P&GQ+>CH5BINIL2"8#`BR:` M@0MTF`'9WG;"DSP(6>,[$N&VLJTI\/%<;SG4X"ZPB`ENBD:$5U5B='>O`3`! M?0]\Y09OU9M`KHL%L;P2/R]%PCPAQX=W/!(F#[JE>QQT432]TK+*13`Y@8`* MW/?A/C\Z*;*>CZ>_&EE[GIC1*UTEKT?=SV87;W.KLXZQ<\+`'>ZPUIW.C[1+ M9-WEU:;;.0X`DS?JY-20.RE"#'C_NQ,8[$1OX=[/?G)9=_SI=O\XJ\H^8A"7 M@O#XEKPH=L>)\2V>YY%:4(<=3Z4C)_C`A&]5TWG,=967ONQQ'X[F=URE$$<\ M%M-Y(]@^7W:.A][3C2^\S[>L904=^,C&9[W@0:YZ)`_BX*P_N^MEM7Q9WU@" MLY=PT9.STL4?_/$=9T""O_]X'H\^ZGV/>^B)7_O1FW[XI3_\CM5?8-4K"-^V MWL5G9_1(_TYZ`L8G?I\F?N:7?I-`?!T'?<:7?%M'>532)FTV'PV2.B^':N-F M8R`F>C3FR:W)MQV?V]V"./U>;K6;=`';@[H>X#G(N_W A@30(>&S"&&R]QH)HIV4I1R75%WNU9WBCP"8\.&F!```[ ` end
-----END PRIVACY-ENHANCED MESSAGE-----